Winton Capital »

Candel Therapeutics shares owned by Winton Capital

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Winton Capital from 13F filings

Historical chart of Winton Capital investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Winton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Winton Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $384k 37k 10.30

More positions owned by Winton Capital

Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Solstice Advanced Matls Com Shs (SOLS)
Kla Corp Com New (KLAC)
Masco Corporation (MAS)
Cme (CME)
CSX Corporation (CSX)
Incyte Corporation (INCY)
Entegris (ENTG)
Crowdstrike Hldgs Cl A (CRWD)
Public Storage (PSA)
AES Corporation (AES)
Powell Industries (POWL)

View all positions for Winton Capital

Top funds holding Candel Therapeutics

FMR
Rtw Investments
BlackRock
Acorn Capital Advisors
Portolan Capital Management
Saturn V Capital Management
Vanguard Capital Management
Geode Capital Management
Millennium Management
State Street Corporation
Halter Ferguson Financial
Northern Trust
Kennedy Capital Management
Vanguard Portfolio Management
Vanguard Fiduciary Trust

View all funds holding Candel Therapeutics